Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
Minocha M, Tran JQ, Sheridan JP, Othman AA
Clin Pharmacokinet. 2015 Aug 5. PMID: 26242380.Abstract
